Analyst price target hikes drive the rally. RXO, Inc. (NYSE: RXO) shares surged 9.2% to $13.06 on March 17, adding roughly $180 million in market capitalization. The stock now trades at a market cap of $2.14 billion.
Three firms raised targets in recent weeks. Barclays lifted its price target to $17 from $15 on March 4 while maintaining an Overweight rating. Truist Securities raised its target to $20 from $18 on February 9, reiterating a Buy rating. Citigroup also bumped its target to $18 from $15 the same day, keeping a Neutral stance. The cluster of upgrades—particularly Truist’s $20 target, which implies 53% upside from current levels—appears to have catalyzed today’s move.
Volume runs light despite the gain. Trading volume reached 1.27 million shares, roughly 51% of the stock’s average daily volume of 2.49 million shares. The below-average turnover suggests the rally may reflect positioning by existing holders rather than broad new buying interest.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.
The post RXO Stock Jumps 9.2% as Three Major Banks Raise Price Targets, Truist Sees 53% Upside first appeared on Alphastreet.
